Millennium Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $5.17M | Buy |
|
|||||
|
2025
Q2 | $1.55M | Buy |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $2.2M | Buy |
|
|||||
|
2024
Q2 | $1M | Buy |
|
|||||
|
2024
Q1 | $1.28M | Sell |
|
|||||
|
2023
Q4 | $2.5M | Sell |
|
|||||
|
2023
Q3 | $4.24M | Buy |
|
|||||
|
2023
Q2 | $6.03M | Buy |
|
|||||
|
2023
Q1 | $58K | Sell |
|
|||||
|
2022
Q4 | $2.25M | Buy |
|
|||||
|
2022
Q3 | $2.17M | Buy |
|
|||||
|
2022
Q2 | $405K | Sell |
|
|||||
|
2022
Q1 | $770K | Buy |
|
|||||
|
2021
Q4 | $1M | Buy |
|
|||||
|
2021
Q3 | $375K | Sell |
|
|||||
|
2021
Q2 | $826K | Sell |
|
|||||
|
2021
Q1 | $1.08M | Sell |
|
|||||
|
2020
Q4 | $3.17M | Buy |
|
|||||
|
2020
Q3 | $186 | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $5.43M | Buy |
|
|||||
|
2019
Q3 | $3.67M | Buy |
|
|||||
|
2019
Q2 | $225K | Sell |
|
|||||
|
2019
Q1 | $242K | Sell |
|
|||||
|
2018
Q4 | $632K | Buy |
|
|||||
|
2018
Q3 | $889K | Sell |
|
|||||
|
2018
Q2 | $5.15M | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $3.77M | Sell |
|
|||||
|
2017
Q3 | $4.72M | Sell |
|
|||||
|
2017
Q2 | $11.4M | Buy |
|
|||||
|
2017
Q1 | $2.65M | Sell |
|
|||||
|
2016
Q4 | $3.14M | Sell |
|
|||||
|
2016
Q3 | $8.31M | Buy |
|
|||||
|
2016
Q2 | $6.42M | Sell |
|
|||||
|
2016
Q1 | $12.9M | Buy |
|
|||||
|
2015
Q4 | $11.3M | Buy |
|
|||||
|
2015
Q3 | $3.43M | Buy |
|
|||||
|
2015
Q2 | $678K | Buy |
|
|||||
|
2015
Q1 | $148K | Sell |
|
|||||
|
2014
Q4 | $302K | Buy |
|